Skip to main content

Table 1 Partial list of the active kinases identified in the siRNA library screen

From: Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumor-initiating cells

Accession number

Symbol

Brief description

Growth inhibition

(%)

NM-001786

CDC2

Cell-division cycle 2, G1 to S and G2 to M

68a

NM-033487

CDC2L1

Cell-division cycle 2-like 1 (PITSLRE proteins)

71

NM-001274

CHEK1

CHK1 checkpoint homolog (S. pombe)

61

NM-001896

CSNK2A2

Casein kinase 2, alpha prime polypeptide

62a

NM-001929

DGUOK

Deoxyguanosine kinase

61

NM-000162

GCK

Glucokinase (hexokinase 4, maturity-onset diabetes of the young 2)

62

NM-153273

IHPK1

Inositol hexaphosphate kinase 1

55

NM-001569

IRAK1

Interleukin-1 receptor-associated kinase 1

59

XM-498294

LOC392265

Similar to cell-division protein kinase 5 (tau protein kinase II catalytic subunit) (TPKII catalytic subunit) (serine/threonine-protein kinase PSSALRE)

67

NM-005922

MAP3K4

Mitogen-activated protein kinase kinase kinase 4

57

NM-015133

MAPK8IP3

Mitogen-activated protein kinase 8 interacting protein 3

56

NM-006206

PDGFRA

Platelet-derived growth factor receptor, alpha polypeptide

63

NM-006212

PFKFB2

6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 2

60

NM-012395

PFTK1

PFTAIRE protein kinase 1

53

NM-000294

PHKG2

Phosphorylase kinase, gamma 2 (testis)

65

NM-018323

PI4K2B

Phosphatidylinositol 4-kinase type-II beta

51a

NM-004570

PIK3C2G

Phosphoinositide-3-kinase, class 2, gamma polypeptide

69a

NM-002651

PIK4CB

Phosphatidylinositol 4-kinase, catalytic, beta polypeptide

56

NM-181805

PKIG

Protein kinase (cAMP-dependent, catalytic) inhibitor gamma

65

NM-002658

PLAU

Plasminogen activator, urokinase

57

NM-005030

PLK1

Polo-like kinase 1 (Drosophila)

86a

NM-006254

PRKCD

Protein kinase C, delta

60

NM-016457

PRKD2

Protein kinase D2

60

NM-021135

RPS6KA2

Ribosomal protein S6 kinase, 90 kDa, polypeptide 2

50

NM-005983

SKP2

S-phase kinase-associated protein 2 (p45)

61

NM-003318

TTK

TTK protein kinase

64

NM-031432

UCK1

Uridine-cytidine kinase 1

63

NM-006296

VRK2

Vaccinia-related kinase 2

55

  1. aApoptosis is at least 5% more than the control for both siRNA sequences of the kinase, as measured by HCS system, based on nuclear properties (morphology and Hoechst dye intensity) of the cells. Note: Growth inhibition resulted from siRNA silencing of SUM149 cells at 5 nM for 72 hours. Data shown here are the average results of both siRNA sequences of the kinase from two independent screens. For a complete list of active kinases identified in the siRNA library screen, refer to Additional file 1.